Vivian T Martins
Overview
Explore the profile of Vivian T Martins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lage D, Vale D, Maia F, Martins V, Silva M, Galvani N, et al.
Parasitology
. 2024 Nov;
:1-13.
PMID: 39604215
Visceral leishmaniasis (VL) is a tropical disease that can be fatal if acute and untreated. Diagnosis is difficult, the treatment is toxic and prophylactic vaccines do not exist. parasites express...
2.
Assis B, Chaves A, Lage D, Cardoso M, Pereira I, Camara R, et al.
Diagn Microbiol Infect Dis
. 2024 May;
109(3):116338.
PMID: 38718661
The diagnosis if leprosy is difficult, as it requires clinical expertise and sensitive laboratory tests. In this study, we develop a serological test for leprosy by using bioinformatics tools to...
3.
Assis B, Chaves A, Lage D, Cardoso M, Freitas C, Pereira I, et al.
Tuberculosis (Edinb)
. 2024 Apr;
147:102505.
PMID: 38583359
Leprosy diagnosis is difficult due to the clinical similarity with other infectious diseases, and laboratory tests presents problems related to sensitivity and/or specificity. In this study, we used bioinformatics to...
4.
Pereira I, Freitas C, Camara R, Jesus M, Lage D, Tavares G, et al.
Exp Parasitol
. 2024 Mar;
260:108743.
PMID: 38513973
Treatment against leishmaniasis presents problems, mainly due to the toxicity of the drugs, high cost, and the emergence of resistant strains. A previous study showed that two vanillin-derived synthetic molecules,...
5.
Freitas C, Pereira I, Lage D, Vale D, Pimenta B, Soares N, et al.
Cytokine
. 2024 Feb;
177:156543.
PMID: 38373365
Treatment against visceral leishmaniasis (VL) presents problems, mainly related to drug toxicity, high cost and/or by emergence of resistant strains. In the present study, two vanillin synthetic derivatives, 3 s...
6.
Jesus M, Lage D, Vale D, Freitas C, Pimenta B, Moreira G, et al.
Parasitol Res
. 2023 Sep;
122(12):2917-2931.
PMID: 37768367
Tegumentary leishmaniasis (TL) is the main clinical manifestation of leishmaniasis, and it can cause the infected hosts to self-healing cutaneous lesions until mutilating scars in mucosal membranes, particularly in the...
7.
Ramos F, Pereira I, Cardoso M, Bandeira R, Lage D, Scussel R, et al.
Viruses
. 2023 Sep;
15(9).
PMID: 37766284
The impact of the COVID-19 pandemic caused by the SARS-CoV-2 virus underscored the crucial role of laboratorial tests as a strategy to control the disease, mainly to indicate the presence...
8.
Lage D, Martins V, Vale D, Freitas C, Pimenta B, Moreira G, et al.
Acta Trop
. 2023 Jul;
246:106986.
PMID: 37453579
Treatment of visceral leishmaniasis (VL) is compromised by drug toxicity, high cost and/or the emergence of resistant strains. Though canine vaccines are available, there are no licensed prophylactic human vaccines....
9.
Vale D, Freitas C, Martins V, Moreira G, Machado A, Ramos F, et al.
Biology (Basel)
. 2023 Jun;
12(6).
PMID: 37372136
Visceral leishmaniasis (VL) in the Americas is a chronic systemic disease caused by infection with parasites. The toxicity of antileishmanial drugs, long treatment course and limited efficacy are significant concerns...
10.
Freitas C, Santiago S, Lage D, Antinarelli L, Oliveira F, Vale D, et al.
Exp Parasitol
. 2023 May;
251:108555.
PMID: 37247802
The treatment against leishmaniasis presents problems, mainly due to their toxicity of the drugs, high cost and/or by the emergence of parasite resistant strains. In this context, new therapeutics should...